{"version":"1.0","type":"link","title":"Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.","author_name":"de Klerk DJ 외","author_url":"https://prs-insight.online/author/de%20Klerk%20DJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/74742","thumbnail_width":1200,"thumbnail_height":630}